Grown Rogue Planned Acquisition of PharmaCann’s New York License and Assets via Grown Rogue New York JV

Vireo Growth Inc. Acquires Four Ohio Cannabis Businesses in $208 Million All-Stock Deal

July 31, 2026

Healthcare Services

Vireo Growth Inc. entered into definitive securities purchase agreements to acquire four Ohio entities—FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC—covering eight dispensaries, a cultivation and processing facility, and related real estate. The aggregate purchase price is expected to be approximately $208 million, paid entirely in Vireo subordinate voting shares in three tranches with deferred performance-based clawbacks. Closing is expected in Q4 2026, subject to regulatory approvals and customary closing conditions.

Vireo Growth Inc to Acquire Certain Assets of The Cannabist Company Holdings Inc

July 20, 2026

Healthcare Services

Vireo Growth Inc, through its subsidiary Vireo Health of Arcadia, LLC, entered into a definitive purchase agreement to acquire certain cannabis cultivation, manufacturing, and retail operations from subsidiaries of The Cannabist Company Holdings Inc across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia. The deal consideration is up to US$35 million (subject to regulatory approvals), with closing expected in stages through 2026 and 2027. Vireo expects the transaction to add up to 25 dispensaries and strengthen its vertically integrated presence in multiple limited-license cannabis markets.

Granite Creek Capital Partners Acquires NYP Corp.

November 14, 2023

Manufacturing

Granite Creek Capital Partners, a Chicago-based private investment firm, has acquired NYP, LLC (d/b/a NYP Corp.), a value-added packaging manufacturer and distributor headquartered in Elizabeth, New Jersey. As part of the transaction Robert Dahl was named CEO and Granite Creek partners joined NYP's board; sellers included long-time owner-operators Christopher and Jerry LaBelle. Granite Creek said it will support product diversification, expansion, and continued growth at the company.

RK Pharma Inc Acquires VGYAAN Pharmaceuticals LLC

June 15, 2023

Pharmaceuticals

RK Pharma Inc., a vertically integrated pharmaceutical company based in Pearl River, New York, has completed the acquisition of VGYAAN Pharmaceuticals LLC, a specialty pharmaceutical company headquartered in Skillman, New Jersey. The deal brings VGYAAN's product portfolio and experienced management team into RK Pharma's vertically integrated platform, enhancing capabilities across complex product development, APIs and finished-dosage manufacturing; terms were not disclosed.

22nd Century Group Acquires RX Pharmatech Ltd

January 24, 2023

Food & Beverage

22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.

Grown Rogue Acquires 30,000 Sq Ft Indoor Facility from Acreage Holdings' HSCP, LLC

April 19, 2022

Agriculture

Grown Rogue International Inc. completed the acquisition of a state-of-the-art 30,000 sq ft indoor cultivation facility in Medford, Oregon from HSCP, LLC (a subsidiary of Acreage Holdings Inc.) on April 14, 2022 for total consideration of $2.0 million. The asset is currently producing approximately 800 lbs/month and expands Grown Rogue's total indoor capacity to 127,000 sq ft, supporting the company’s production and margin targets.